Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution

BACKGROUND: Focal treatment for prostate cancer (PCa) is a hybrid approach combining ablative treatment of the involved prostate gland and continued active surveillance (AS) of the unaffected gland. Low dose-rate (LDR) brachytherapy can be used as a lesion-targeted focal therapy, however, further st...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Elliot, Smyth, Lloyd M. L., O’Sullivan, Richard, Ryan, Andrew, Lawrentschuk, Nathan, Grummet, Jeremy, See, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511546/
https://www.ncbi.nlm.nih.gov/pubmed/34733655
http://dx.doi.org/10.21037/tau-21-508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511546/
https://www.ncbi.nlm.nih.gov/pubmed/34733655
http://dx.doi.org/10.21037/tau-21-508

Ejemplares similares